Interstitial lung disease in anti-MDA5 positive dermatomyositis

W Wu, L Guo, Y Fu, K Wang, D Zhang, W Xu… - Clinical reviews in …, 2021 - Springer
Anti-melanoma differentiation-associated gene 5–positive dermatomyositis (MDA5+ DM) is
a rare autoimmune disease predominantly reported in East Asia. MDA5+ DM is an …

Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: a systematic review

M McPherson, S Economidou, A Liampas, P Zis… - Seminars in Arthritis and …, 2022 - Elsevier
Introduction Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive
clinically amyopathic dermatomyositis (CADM) is frequently associated with rapidly …

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung …

F Romero-Bueno, PD Del Campo… - Seminars in arthritis and …, 2020 - Elsevier
Objectives The study aimed to develop evidence-based recommendations for the treatment
of rapidly progressive interstitial lung disease (RPILD) associated with the anti-Melanoma …

Prevalence of interstitial lung disease in polymyositis and dermatomyositis: a meta-analysis from 2000 to 2020

KY Sun, Y Fan, YX Wang, YJ Zhong… - Seminars in arthritis and …, 2021 - Elsevier
Objective Interstitial lung disease (ILD) is the most important prognostic factor for mortality in
patients with polymyositis (PM) and dermatomyositis (DM), but the prevalence of ILD in …

Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis/dermatomyositis–associated interstitial lung disease

T Gono, K Masui, N Nishina, Y Kawaguchi… - Arthritis & …, 2021 - Wiley Online Library
Objective To establish predictive models for mortality in patients with polymyositis/
dermatomyositis–associated interstitial lung disease (PM/DM‐ILD) using a combination of …

2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease

Y Kondoh, S Makino, T Ogura, T Suda, H Tomioka… - Respiratory …, 2021 - Elsevier
The prognosis of patients with connective tissue disease (CTD) has improved significantly in
recent years, but interstitial lung disease (ILD) associated with connective tissue disease …

Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 …

J So, H So, VTL Wong, R Ho, TY Wu, PCH Wong… - …, 2022 - academic.oup.com
Objective Anti-melanoma differentiation-associated protein 5 (MDA5)-positive DM is
associated with rapidly progressive interstitial lung disease (RP-ILD) and high mortality. This …

Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients

S Sato, K Masui, N Nishina, Y Kawaguchi… - …, 2018 - academic.oup.com
Objective To identify initial predictors of poor survival in patients with PM/DM-associated
interstitial lung disease (ILD). Methods We established a multicentre retrospective cohort of …

[HTML][HTML] Diagnosis and management of myositis-associated lung disease

RW Hallowell, SK Danoff - Chest, 2023 - Elsevier
Although interstitial lung disease (ILD) is a leading cause of morbidity and mortality in
patients with inflammatory myopathies, the current definition and diagnostic criteria of …

Interstitial lung disease in polymyositis and dermatomyositis

K Long, SK Danoff - Clinics in Chest Medicine, 2019 - chestmed.theclinics.com
The idiopathic inflammatory myopathies (IIMs) are a diverse group of connective tissue
diseases characterized by varying degrees of muscle inflammation and systemic …